This page shows the latest Vaxigrip news and features for those working in and with pharma, biotech and healthcare.
Sanofi is still to have its four-strain vaccine recommended in the EU, however, although it was accepted for review by the EMA under the brand name Vaxigrip in April. ... The vaccine is also approved for the youngest patient population in Europe, as
Pharma company also launches production of ingredient for malaria drug. Sanofi's four-strain (quadrivalent) influenza vaccine Vaxigrip has been accepted by the European Medicines Agency (EMA) for review for approval ... If approved, Vaxigrip will be
hexavalent vaccine (DTP-Hep B-Polio-Hib), as well as a filing in the EU for Sanofi's quadrivalent flu vaccine Vaxigrip QIV.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...